Arrhythmias in Patients with Cardiac Amyloidosis: A Comprehensive Review on Clinical Management and Devices
Journal of Cardiovascular Development and Disease · 05.08.2023 · 10 (8) · 337
DOI: 10.3390/jcdd10080337 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cardiovascular Development and Disease, online erschienen am 05.08.2023. Verfasst von Alexandros Briasoulis und 8 weiteren Autor:innen. Beteiligte Einrichtung: Medical School of Athens, National and Kapodistrian University of Athens, 15772 Athens, Greece. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cardiac amyloidosis (CA) is a rare but potentially life-threatening disease in which misfolded proteins accumulate in the cardiac wall tissue. Heart rhythm disorders in CA, including supraventricular arrhythmias, conduction system disturbances, or ventricular arrhythmias, play a major role in CA morbidity and mortality, and thus require supplementary management. Among them, AF is the most frequent arrhythmia during CA hospitalizations and is associated with significantly higher mortality, while ventricular arrhythmias are also common and are usually associated with poor prognosis. Early diagnosis of potential arrythmias could be performed through ECG, Holter monitoring, and/or electrophysiology study. Clinical management of these patients is quite significant, and it usually includes initiation of amiodarone and/or digoxin in patients with AF, potential electrical cardioversion, or ablation in specific patients with indication, as well as initiation of anticoagulants in all patients, independent of AF and CHADS-VASc score, for potential intracardiac thrombus. Moreover, identification of patients with conduction disorders that could benefit from prophylactic pacemaker implantation and/or CRT as well as identification of patients with life-threatening ventricular arrythmias that could benefit from ICD could both increase the survival rates of these patients and improve their quality of life.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical School of Athens, National and Kapodistrian University of Athens, 15772 Athens, Greece.
- Department of Cardiology, University Hospital of Larissa, 41110 Larissa, Greece.
- Department of Cardiology, Hygeia Hospital, 15123 Athens, Greece.
ORCID-Profile: Alexandros Briasoulis, Christos Kourek, Andrew Xanthopoulos
Zitieren
APA
Briasoulis, A., Kourek, C., Papamichail, A., Loritis, K., Bampatsias, D., Repasos, E., Xanthopoulos, A., Tsougos, E., & Paraskevaidis, I. (2023). Arrhythmias in Patients with Cardiac Amyloidosis: A Comprehensive Review on Clinical Management and Devices. Journal of Cardiovascular Development and Disease, 10(8), 337. https://doi.org/10.3390/jcdd10080337
Vancouver
Briasoulis A, Kourek C, Papamichail A, Loritis K, Bampatsias D, Repasos E, et al. Arrhythmias in Patients with Cardiac Amyloidosis: A Comprehensive Review on Clinical Management and Devices. Journal of Cardiovascular Development and Disease. 2023;10(8):337. doi:10.3390/jcdd10080337
BibTeX
@article{Briasoulis2023,
author = {Briasoulis, Alexandros and Kourek, Christos and Papamichail, Adamantia and Loritis, Konstantinos and Bampatsias, Dimitrios and Repasos, Evangelos and Xanthopoulos, Andrew and Tsougos, Elias and Paraskevaidis, Ioannis},
title = {Arrhythmias in Patients with Cardiac Amyloidosis: A Comprehensive Review on Clinical Management and Devices},
journal = {Journal of Cardiovascular Development and Disease},
year = {2023},
volume = {10},
number = {8},
pages = {337},
doi = {10.3390/jcdd10080337}
}
EUVIMED